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Abstract 
Objective: To determine prognostic factors influencing prolonged ventilation after surgery in our 
hospital. Method: Seventy-five patients fulfilled inclusion criteria were included in this retrospective 
cross-sectional study. Prognostic factors analyzed were age, chronic pulmonary disease, heart failure 
(NYHA class function), left ventricular (LV) dysfunction (based on ejection fraction), recent myocardial 
infarction, pulmonary hypertension (PH), duration of cardiopulmonary bypass (CPB), ischemic time 
and aorta clamp time, which were analyzed in relation to prolonged ventilation after open mitral valve 
surgery. Results: Subjects were 75 patients aged between 19 and 62 years old (mean 39.76, SD 11.44) 
whom underwent open mitral valve repair or replacement surgery. Twenty-three patients (30.67%) 
had prolonged ventilation (≥24 hours) after surgery. Bivariate analysis showed there were no 
significant correlation between age, heart failure, PH and LV dysfunction. There are different with 
statistically significance between groups (p<0.05). Conclusions: In this study, almost one-third of 
patients had prolonged ventilation after surgery. Factors influencing this morbidity were the duration 
of ischemic time, aorta clamp time and CPB. Age, heart failure, LV dysfunction and PH were not 
statistically related to the prolonged ventilation event. 
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INTRODUCTION 
The global epidemiology of valvular heart 
disease has changed dramatically recently. 
Rheumatic heart disease (RHD) which was 
the main cause of valvular heart disease 
prior to World War II, has now reduced its 
incidence, due to the development of new 
antibiotics and improvement of healthcare 
system, especially in developing countries. 
At the same time, life expectancy 
increases, and the prevalence of age-
related valvular heart disease (e.g. 
degenerative valve disease) increases. The 
presence of valvular heart disease (VHD) 
has a statistically significant impact on 
mortality, underscoring the fact that VHD 
is a significant health problem.1 
Surgical intervention is the main 
management of moderate to severe 
valvular heart disease. Despite the 
expensive cost for the procedure, access to 
medical procedures increases with 
economic improvement.2 Cardiac surgery 
itself is an operation performed to correct 
anatomic or cardiac function. Types of 
cardiac surgery include Coronary Artery 
Bypass Graft (CABG) surgery, heart valve 
repair or replacement surgery and other 
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operations. This heart surgery procedure is 
can be performed in two ways, by stopping 
the heart temporarily (on-pump) or 
surgery with the heart that is still throbbing 
(off-pump).3 
Although postoperative mortality is the 
most important clinical data, mortality 
alone is no longer considered sufficient to 
assess patient’s outcome. It is clearly 
recognized that non-fatal postoperative 
complications can significantly affect the 
patient's functional status and quality of 
life. Therefore, the identification of factors 
and the calculation of risk to the level of 
morbidity in cardiac surgery patients can 
provide valuable insights into improving 
the quality of patient care.4 In addition to 
being a widely used predictor of mortality, 
EuroSCORE has proven to be a good 
predictor of postoperative morbidity in 
cardiac surgery.5 
From the prior studies by Priyatno6 and 
Asmaya7, it was found that the most 
common post mitral valve surgery 
morbidity found in Dr. Sardjito General 
Hospital was postoperative prolonged 
ventilation, which is defined as the need of 
mechanical ventilation until ≥24 hours 
post-surgery. The need of prolonged 
ventilation certainly brings medical, social, 
and economic implications directly to the 
patients. Although the identification of 
factors and the calculation of risks to the 
level of morbidity in cardiac surgery 
patients is very useful, there has never 
been any research on prognostic factors 
that affect prolonged ventilation after 
mitral valve surgery at Dr. Sardjito General 
Hospital. 
METHODS 
This study was a retrospective cross-
sectional study. A total of 75 patients who 
met the inclusion criteria (patients 
underwent mitral valve surgery in the 
2012-2017 period at Dr. Sardjito General 
Hospital) were included by purposive 
sampling in this study. The exclusion 
criteria used were incomplete medical 
record data, the patient underwent non-
surgical correction or a patient with a 
history of previous heart surgery. 
Preoperative factors consist of age, chronic 
lung disease, heart failure, left ventricular 
dysfunction (assessed from the ejection 
fraction), recent MI (myocardial infarction 
in the past 90 days) and pulmonary 
hypertension while intraoperative factors 
were the duration of CPB, ischemic time 
and aortic clamp time. The dependent 
variable is the incidence of prolonged 
ventilation (≥24 hours) postoperatively. 
The correlation between independent and 
dependent variables was analyzed 
statistically. 
RESULTS AND DISCUSSIONS 
Subjects were aged between 19 years and 
62 years (mean age 39.76 years with a 
standard deviation of 11.44), with 2 
subjects aged ≥60 years and 73 subjects 
aged <60 years. In the age group ≥60 years, 
there were 1.3% morbidity (1 subject). 
While in the <60 years group, morbidity 
was found in 22 (29.3%) subjects. In the 
age group ≥60 years, bivariate analysis 
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performed with Chi square found p = 0.548 
with a confidence level <0.05. So it was 
concluded that age ≥60 years did not 
significantly influence the incidence of 
postoperative morbidity. 
Mortality and morbidity of surgery 
increase with increasing age in patients 
undergoing surgery. Although this risk is 
partly a result of increased comorbidity, 
age is an independent and strong risk 
factor for morbidity.8 Patients with age 
above 50 years have mortality and 
morbidity risk factors in patients with ICU 
care because patients aged over 50 years 
usually experience a lot of comorbid 
factors.9 In the research by Ruiz et al., it 
was found that the occurrence of 
atherosclerosis is accelerated with 
increasing age.9 The effect of advanced age 
on patients is doubled. In the elderly it is 
characterized by an increase in circulating 
fibrinogen and factor VII. This damage 
contributes to increasing thrombogenesis 
through the effects of damage to 
endothelial function with disruption of 
fibrinolytic activity and coronary 
vasodilator response.10 In this study it was 
found that age ≥60 years had no 
statistically significant effect on the 
incidence of morbidity (prolonged 
ventilation) after mitral valve surgery. This 
research finding were contrast to Nashef's 
research, said that age ≥60 years has an 
effect on postoperative cardiac 
morbidity.11 This difference result is 
probably associated with the different 
anatomical characteristics and life 
expectancy of Europeans from those of 
Indonesians, and also the number of 
subject samples was too small (only 2 
patients out of a total of 75 patients). 
In the data of patients with symptoms of 
heart failure, there were three classes of 
subjects, namely subjects who had 
symptoms of heart failure according to 
NYHA functional classes I, II and III. There 
were 5 patients included in the NYHA 
Functional Class I group, in which 1 subject 
(1.33%) with morbidity and 4 subjects 
(5.33%) without morbidity. In the NYHA 
Group Functional Class II there were 61 
subjects, of which 20 (26.67%) with 
morbidity and 41 subjects (54.67%) 
without morbidity. In the NYHA Group III 
Functional Class there were 9 subjects, of 
which 2 (26.7%) with morbidity and 7 
subjects (9.33%) without morbidity. P-
value was 0.705 so it was concluded that 
the degree of preoperative heart failure 
was not related to the incidence of 
prolonged ventilation after mitral valve 
surgery. 
A study by Azarfarin (2014), revealed that 
patients with heart failure functional 
classes III and IV increased ICU length of 
stay, postoperative stroke incidence and 
postoperative kidney failure.12 In this study 
the status of patients with clinical heart 
failure functional class IV was not found. 
This is likely because patients with 
functional IV grade heart failure rarely 
achieve optimal conditions for surgery. A 
previous study found that patients with 
clinical functional class III and IV heart 
failure had 3 years lower survival rates 
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than patients with clinical I and II 
functional classes.13
Table 1. Patients Demographic and the Incidence of Prolonged Ventilation 
Variables n (%) Ventilation duration 
≥24 hours (%) <24 hours (%) 
Age    
<60 years old 73 (97.33) 22 (29.33) 51 (68) 
≥60 years old 2 (2.67) 1 (1.33) 1 (1.33) 
Chronic lung disease    
Positive 0 (0) 0 (0) 0 (0) 
Negative 75 (100) 23 (30.67) 52 (69.33) 
Heart failure (NYHA class function)    
CHF cf I (NYHA 1) 5 (6.67) 1 (1.33) 4 (5.33) 
CHF cf II (NYHA 2) 61 (81.33) 20 (26.67) 41 (54.67) 
CHF cf III (NYHA 3) 9 (12) 2 (2.67) 7 (9.33) 
CHF cf IV (NYHA 4) 0 (0) 0 (0) 0 (0) 
Left ventricular (LV) dysfunction    
Normal (LVEF >50%) 66 (88) 20 (26.67) 46 (61.33) 
Moderate (LVEF 30-50%) 9 (12) 3 (4) 6 (8) 
Severe (LVEF <30%) 0 (0) 0 (0) 0 (0) 
Recent MI    
Positive 0 (0) 0 (0) 0 (0) 
Negative 75 (100) 23 (30.67) 52 (69.33) 
Pulmonal hypertension    
Mild 22 (29.33) 4 (5.33) 18 (24) 
Moderate 24 (32.00) 7 (9.33) 17 (22.67) 
Severe 29 (38.67) 12 (16) 17 (22.67) 
 
Preoperative left ventricular function 
impairment was defined as left ventricular 
ejection fraction (LVEF) <50% in 
measurements using preoperative 
echocardiography. In this study, there 
were 9 patients with left ventricular 
function impairment, with 3 patients (4%) 
having postoperative morbidity and 6 (8%) 
without postoperative morbidity. In the 
group without impaired ventricular 
function there were 66 subjects, of which 
20 subjects (26.67%) with morbidity and 46 
(61.33%) without postoperative morbidity. 
P-value was found to be 0.853 so it can be 
concluded that there was no significant 
relationship between impaired left 
ventricular function before surgery and 
postoperative prolonged ventilation 
morbidity. 
The vital function of the left ventricle is to 
pump blood to all organs of the body 
including the vital organs such as brain, 
kidneys and lungs. In postoperative 
patients with poor left ventricular function 
capital coupled with severe operating 
stressors will result in organ damage due to 
oxygen supply and food that is not optimal. 
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The damage can manifest as postoperative 
stroke, impaired renal function or 
prolongation of ventilator use due to 
impaired development of less optimal 
pulmonary ventilation.5 
In the pulmonary hypertension data, there 
were three groups of subjects, namely 
subjects with mild pulmonary 
hypertension (pulmonary artery systolic 
pressure 25-40 mmHg), moderate 
(pulmonary artery systolic pressure 41-55 
mmHg) and severe (pulmonary artery 
systolic pressure >55 mmHg). There were 
22 patients included in the mild pulmonary 
hypertension group, in which 4 subjects 
(5.33%) with morbidity and 18 subjects 
(24%) without morbidity. In the group of 
patients with moderate pulmonary 
hypertension there were 24 subjects, of 
which 7 (9.33%) with morbidity and 17 
subjects (22.67%) without morbidity. In the 
group of patients with severe pulmonary 
hypertension there were 29 subjects, of 
which 12 (16%) with morbidity and 17 
subjects (22.67%) without morbidity. P-
value was 0.202, so it was concluded that 
the degree of preoperative pulmonary 
hypertension was not related to the 
incidence of prolonged ventilation after 
mitral valve surgery.
Table 2. Pearson’s Chi-square test 
Variables Ventilation duration p-value 
≥24 hours <24 hours 
Age   0.548 
<60 years old 22 51 
≥60 years old 1 1 
Heart failure   0.705 
NYHA 1 1 4 
NYHA 2 20 41 
NYHA 3 2 7 
NYHA 4 0 0 
LV dysfunction   0.853 
Normal 20 46 
Moderate 3 6 
Severe 0 0 
Pulmonal hypertension   0.20 
Mild 4 18 
Moderate 7 17 
Severe 12 17 
Aorta Clamp (median) 112’53” 72’09” 0.01 
Ischemic Time (median) 103’35” 60’12” 0.02 
CPB duration (median) 139’08” 104’05” 0.02 
 
For intraoperative data, we analyzed CPB 
duration, aortic clamp and ischemic time in 
all patients. The median values for 
duration of CPB, aortic clamp and ischemic 
time in living patients with positive 
morbidity were 139'08", 103'35" and 
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112'53", respectively, while those with 
negative morbidity were 72'09", 60'12" 
and 104'05". Chi-square analysis 
performed on these three variables 
obtained a p-value of 0.02 for the duration 
of CPB and ischemic time and 0.01 for the 
aorta clamp time. Thus it is said that the 
variable duration of CPB, aortic clamp time 
and ischemic time are significantly 
associated with prolonged ventilation after 
mitral valve surgery. 
This finding resembles the results of 
Azarfarin's (2014) study of factors related 
to the increased of length of stay after 
open heart surgery which stated that age 
>50 years, duration of surgery and CPB 
duration had a significant effect on ICU 
length of stay.12 Another study that 
discussed the duration of CPB was carried 
out by Salis et al. (2008) which states that 
CPB duration is an independent predictor 
of postoperative cardiac morbidity and 
mortality. The type of morbidity studied by 
Salis et al. are postoperative blood loss, 
length of ICU treatment, total length of 
hospital stays, multiple RBC transfusions, 
surgery due to bleeding, respiratory, 
neurological, infection, and kidney 
complications.14 
CONCLUSSIONS 
In this study, about one third of patients 
experienced prolonged ventilation after 
mitral valve surgery. Factors that influence 
this event are the duration of ischemic 
time, aortic clamp time and CPB. Age 
factors, heart failure, left ventricular 
dysfunction, and pulmonary hypertension 
were not significantly associated with 
ventilator use  24 hours. We suggest to do 
research with a better design to assess the 
factors that can influence the incidence of 
prolonged ventilation after mitral valve 
surgery in Dr. Sardjito General Hospital.15 
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